BlackRock’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $247M | Buy |
|
|||||
|
2025
Q2 | $181M | Sell |
|
|||||
|
2025
Q1 | $117M | Sell |
|
|||||
|
2024
Q4 | $175M | Buy |
|
|||||
|
2024
Q3 | $199M | Buy |
|
|||||
|
2024
Q2 | $124M | Buy |
|
|||||
|
2024
Q1 | $147M | Buy |
|
|||||
|
2023
Q4 | $90.8M | Buy |
|
|||||
|
2023
Q3 | $46.7M | Buy |
|
|||||
|
2023
Q2 | $74.2M | Sell |
|
|||||
|
2023
Q1 | $98.7M | Sell |
|
|||||
|
2022
Q4 | $83.2M | Buy |
|
|||||
|
2022
Q3 | $69.8M | Buy |
|
|||||
|
2022
Q2 | $55.7M | Sell |
|
|||||
|
2022
Q1 | $145M | Buy |
|
|||||
|
2021
Q4 | $216M | Buy |
|
|||||
|
2021
Q3 | $179M | Buy |
|
|||||
|
2021
Q2 | $119M | Buy |
|
|||||
|
2021
Q1 | $58.8M | Buy |
|
|||||
|
2020
Q4 | $87.8M | Buy |
|
|||||
|
2020
Q3 | $24.8M | Buy |
|